Society Information
The aims of the European Organisation for Research and Treatment of Cancer (EORTC) are to conduct, develop, coordinate, and stimulate laboratory and clinical research in Europe to improve the management of cancer and related problems by increasing survival but also patients' quality of life.
The European CanCer Organisation exists to:
- Uphold the right of all European cancer patients to the best possible treatment and care
- Promote interaction between all organisations involved in cancer research, education, treatment and care at the European level.
It does this by:
- Creating awareness of patients needs and wishes
- Encouraging progressive thinking in cancer policy, training and education
- Promoting European cancer research through the organisation of international multidisciplinary meetings
The European Association for Cancer Research (EACR) has always had one guiding aim 'The advancement of cancer research'. In pursuing this aim, the Association provides services to members, presents educational, training and scientific meeting opportunities, and facilitates communication and collaboration between the cancer researchers who make up its membership. It also sets out to raise the profile of cancer research and cancer researchers in Europe and the need for sustained political and economic support.
With almost 8,000 members, the EACR is Europe's largest member society for cancer research. The Association enjoys particularly strong links with other European cancer societies and is a founder member of the European Cancer Organisation (ECCO).
The European Society of Breast Cancer Specialists (EUSOMA) is a multidisciplinary society committed to increase contacts among specialists in Breast Cancer, improve and harmonise the quality of patient care in Europe, encourage the multidisciplinary approach and the establishment of Breast Units, foster a voluntary certification process. The main society activities are the publication of consensus statements on new controversial aspects in breast cancer care and the promotion of training and qualification of breast cancer specialists through training programmes for young MDs.
